Point72 Asset Management
GBT

Point72 Asset Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Point72 Asset Management’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,524,485
Closed -$48.7M – 1841
2022
Q2 		$48.7M Buy
1,524,485
+604,285
+66% +$17.7M 0.21% 126
2022
Q1 		$31.9M Buy
920,200
+736,729
+402% +$22M 0.13% 216
2021
Q4 		$5.37M Sell
183,471
-2,129,129
-92% -$66M 0.02% 647
2021
Q3 		$58.9M Buy
2,312,600
+251,000
+12% +$7.38M 0.26% 82
2021
Q2 		$72.2M Buy
2,061,600
+736,118
+56% +$28.7M 0.32% 64
2021
Q1 		$54M Buy
1,325,482
+1,272,802
+2,416% +$58.5M 0.25% 95
2020
Q4 		$2.28M Buy
+52,680
New +$2.6M 0.01% 711
2020
Q3 		– Sell
-214,113
Closed -$13.6M – 1157
2020
Q2 		$13.5M Sell
214,113
-73,304
-26% -$5.03M 0.09% 274
2020
Q1 		$14.7M Sell
287,417
-177,264
-38% -$11.9M 0.12% 248
2019
Q4 		$36.9M Sell
464,681
-243,127
-34% -$14.4M 0.19% 153
2019
Q3 		$34.3M Buy
+707,808
New +$36.9M 0.21% 136
2018
Q3 		– Sell
-435,900
Closed -$19.7M – 1284
2018
Q2 		$19.7M Buy
+435,900
New +$19.8M 0.08% 307
2018
Q1 		– Sell
-226,300
Closed -$12.6M – 1185
2017
Q4 		$8.9M Sell
226,300
-1,796,400
-89% -$67.1M 0.04% 469
2017
Q3 		$62.8M Buy
2,022,700
+1,323,934
+189% +$37.2M 0.28% 89
2017
Q2 		$19.1M Buy
698,766
+287,666
+70% +$8.56M 0.11% 259
2017
Q1 		$15.1M Buy
+411,100
New +$10.4M 0.08% 300
2016
Q2 		– Sell
-112,300
Closed -$1.78M – 917
2016
Q1 		$1.78M Buy
+112,300
New +$2M 0.01% 570

Other funds holding GBT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Point72 Asset Management's GBT Position: Q3 2022 in Review

Point72 Asset Management sold out of Global Blood Therapeutics, Inc. (GBT) in Q3 2022, closing a stake of 1,524,485 shares — an estimated $48.7M sold.

Point72 Asset Management first reported a position in GBT in Q1 2016 and held it in 17 quarters. The position peaked at $72.2M in Q2 2021. 247 funds tracked by Wall St. Rank hold GBT as of Q3 2022.

  • Point72 Asset Management reported no remaining Global Blood Therapeutics, Inc. position as of Q3 2022 after selling out during the quarter.
  • Point72 Asset Management sold 1,524,485 Global Blood Therapeutics, Inc. shares in Q3 2022, an estimated $48.7M.
  • Point72 Asset Management first reported a position in Global Blood Therapeutics, Inc. in Q1 2016 and held it in 17 quarters.
  • Point72 Asset Management's Global Blood Therapeutics, Inc. position peaked at $72.2M in Q2 2021.
  • 247 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2022.

Based on Point72 Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.